BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 22204334)

  • 1. 2-hydroxy-1-oxo-1,2-dihydroisoquinoline-3-carboxylic acid with inbuilt β-N-hydroxy-γ-keto-acid pharmacophore as HCV NS5B polymerase inhibitors.
    Deore RR; Chen GS; Chen CS; Chang PT; Chuang MH; Chern TR; Wang HC; Chern JW
    Curr Med Chem; 2012; 19(4):613-24. PubMed ID: 22204334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of N-arylalkyl-3-hydroxy-4-oxo-3,4-dihydroquinazolin-2-carboxamide derivatives as HCV NS5B polymerase inhibitors.
    Deore RR; Chen GS; Chang PT; Chern TR; Lai SY; Chuang MH; Lin JH; Kung FL; Chen CS; Chiou CT; Chern JW
    ChemMedChem; 2012 May; 7(5):850-60. PubMed ID: 22383290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. I. Novel HCV NS5B polymerase inhibitors: discovery of indole 2-carboxylic acids with C3-heterocycles.
    Anilkumar GN; Lesburg CA; Selyutin O; Rosenblum SB; Zeng Q; Jiang Y; Chan TY; Pu H; Vaccaro H; Wang L; Bennett F; Chen KX; Duca J; Gavalas S; Huang Y; Pinto P; Sannigrahi M; Velazquez F; Venkatraman S; Vibulbhan B; Agrawal S; Butkiewicz N; Feld B; Ferrari E; He Z; Jiang CK; Palermo RE; McMonagle P; Huang HC; Shih NY; Njoroge G; Kozlowski JA
    Bioorg Med Chem Lett; 2011 Sep; 21(18):5336-41. PubMed ID: 21840715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design and synthesis of lactam-thiophene carboxylic acids as potent hepatitis C virus polymerase inhibitors.
    Barnes-Seeman D; Boiselle C; Capacci-Daniel C; Chopra R; Hoffmaster K; Jones CT; Kato M; Lin K; Ma S; Pan G; Shu L; Wang J; Whiteman L; Xu M; Zheng R; Fu J
    Bioorg Med Chem Lett; 2014 Aug; 24(16):3979-85. PubMed ID: 24986660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 2-(3-Thienyl)-5,6-dihydroxypyrimidine-4-carboxylic acids as inhibitors of HCV NS5B RdRp.
    Pacini B; Avolio S; Ercolani C; Koch U; Migliaccio G; Narjes F; Pacini L; Tomei L; Harper S
    Bioorg Med Chem Lett; 2009 Nov; 19(21):6245-9. PubMed ID: 19800789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C-6 aryl substituted 4-quinolone-3-carboxylic acids as inhibitors of hepatitis C virus.
    Chen YL; Zacharias J; Vince R; Geraghty RJ; Wang Z
    Bioorg Med Chem; 2012 Aug; 20(15):4790-800. PubMed ID: 22748708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and SAR optimization of diketo acid pharmacophore for HCV NS5B polymerase inhibition.
    Bhatt A; Gurukumar KR; Basu A; Patel MR; Kaushik-Basu N; Talele TT
    Eur J Med Chem; 2011 Oct; 46(10):5138-45. PubMed ID: 21893371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple e-pharmacophore modeling, 3D-QSAR, and high-throughput virtual screening of hepatitis C virus NS5B polymerase inhibitors.
    Therese PJ; Manvar D; Kondepudi S; Battu MB; Sriram D; Basu A; Yogeeswari P; Kaushik-Basu N
    J Chem Inf Model; 2014 Feb; 54(2):539-52. PubMed ID: 24460140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The design, synthesis and biological evaluations of C-6 or C-7 substituted 2-hydroxyisoquinoline-1,3-diones as inhibitors of hepatitis C virus.
    Chen YL; Tang J; Kesler MJ; Sham YY; Vince R; Geraghty RJ; Wang Z
    Bioorg Med Chem; 2012 Jan; 20(1):467-79. PubMed ID: 22100256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 3-Hydroxyisoquinolines as inhibitors of HCV NS5b RNA-dependent RNA polymerase.
    Hendricks RT; Spencer SR; Blake JF; Fell JB; Fischer JP; Stengel PJ; Leveque VJ; Lepogam S; Rajyaguru S; Najera I; Josey JA; Swallow S
    Bioorg Med Chem Lett; 2009 Jan; 19(2):410-4. PubMed ID: 19070486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery and initial optimization of alkoxyanthranilic acid derivatives as inhibitors of HCV NS5B polymerase.
    Parcella K; Nickel A; Beno BR; Sheriff S; Wan C; Wang YK; Roberts SB; Meanwell NA; Kadow JF
    Bioorg Med Chem Lett; 2017 Jan; 27(2):295-298. PubMed ID: 27908764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and biological evaluation of a series of 1H-benzo[de]isoquinoline-1,3(2H)-diones as hepatitis C virus NS5B polymerase inhibitors.
    Ontoria JM; Rydberg EH; Di Marco S; Tomei L; Attenni B; Malancona S; Martin Hernando JI; Gennari N; Koch U; Narjes F; Rowley M; Summa V; Carroll SS; Olsen DB; De Francesco R; Altamura S; Migliaccio G; Carfì A
    J Med Chem; 2009 Aug; 52(16):5217-27. PubMed ID: 19877603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis C NS5B polymerase inhibitors: 4,4-Dialkyl-1-hydroxy-3-oxo-3,4-dihydronaphthalene-3-yl benzothiadiazine derivatives.
    Hutchinson DK; Rosenberg T; Klein LL; Bosse TD; Larson DP; He W; Jiang WW; Kati WM; Kohlbrenner WE; Liu Y; Masse SV; Middleton T; Molla A; Montgomery DA; Beno DW; Stewart KD; Stoll VS; Kempf DJ
    Bioorg Med Chem Lett; 2008 Jul; 18(14):3887-90. PubMed ID: 18599294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pyridobenzothiazole derivatives as new chemotype targeting the HCV NS5B polymerase.
    Manfroni G; Meschini F; Barreca ML; Leyssen P; Samuele A; Iraci N; Sabatini S; Massari S; Maga G; Neyts J; Cecchetti V
    Bioorg Med Chem; 2012 Jan; 20(2):866-76. PubMed ID: 22197397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-based virtual screening, synthesis and SAR of novel inhibitors of hepatitis C virus NS5B polymerase.
    Talele TT; Arora P; Kulkarni SS; Patel MR; Singh S; Chudayeu M; Kaushik-Basu N
    Bioorg Med Chem; 2010 Jul; 18(13):4630-8. PubMed ID: 20627595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of new scaffolds for rational design of HCV NS5B polymerase inhibitors.
    Golub AG; Gurukumar KR; Basu A; Bdzhola VG; Bilokin Y; Yarmoluk SM; Lee JC; Talele TT; Nichols DB; Kaushik-Basu N
    Eur J Med Chem; 2012 Dec; 58():258-64. PubMed ID: 23127989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent advances on the synthesis of hepatitis C virus NS5B RNA-dependent RNA-polymerase inhibitors.
    Zhao C; Wang Y; Ma S
    Eur J Med Chem; 2015 Sep; 102():188-214. PubMed ID: 26276434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of novel HCV polymerase inhibitors using pharmacophore-based virtual screening.
    Kim ND; Chun H; Park SJ; Yang JW; Kim JW; Ahn SK
    Bioorg Med Chem Lett; 2011 Jun; 21(11):3329-34. PubMed ID: 21531135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of carboxylic acid replacements in indole-N-acetamide inhibitors of hepatitis C virus NS5B polymerase.
    Stansfield I; Pompei M; Conte I; Ercolani C; Migliaccio G; Jairaj M; Giuliano C; Rowley M; Narjes F
    Bioorg Med Chem Lett; 2007 Sep; 17(18):5143-9. PubMed ID: 17681757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Further SAR studies on novel small molecule inhibitors of the hepatitis C (HCV) NS5B polymerase.
    Reddy TJ; Chan L; Turcotte N; Proulx M; Pereira OZ; Das SK; Siddiqui A; Wang W; Poisson C; Yannopoulos CG; Bilimoria D; L'Heureux L; Alaoui HM; Nguyen-Ba N
    Bioorg Med Chem Lett; 2003 Oct; 13(19):3341-4. PubMed ID: 12951122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.